Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis

Current limited data suggest that amantadine may be the only drug that has relatively sufficient evidences in treatment of fatigue symptoms in MS. Further RCT studies recruiting larger samples sizes are required to validate the therapeutic effect of these candidate drugs.